Austrian Stock Talk 2021

CEO Andreas Grassauer talks about the company and presents recent figures and facts.

Interview with life-science Austria

The nasal spray against SARS-CoV-2 - Interview with Eva Prieschl-Grassauer (CSO) and Andreas Grassauer (CEO)

Find more information here (German only): https://life-science.eu/nasenspray-und-pastillen-wirken-gegen-sars-cov-2/

Fighting autoimmune gastritis

November 2020

In cooperation with the Medical University of Vienna, Marinomed is developing a treatment for autoimmune gastritis. Read the article in the magazine Chemiereport (2020/7) or in their ePaper. (German only)

Interview with the magazine BÖRSIANER

October 2020

Eva Prieschl-Grassauer and Andreas Grassauer talk about SARS-CoV-2 and their assessment of a vaccination against the virus, as well as Marinomed and the history of Carragelose. You can find the interview in the 40th issue of the magazine and here (German only).

Interview with the magazine TREND

August 2020

Eva Prieschl-Grassauer and Andreas Grassauer talk about the Coronavirus, Carragelose and the future of Marinomed (issue 33/2020). Read the full article here (German only).